Fedratinib hydrochloride
| Fedratinib hydrochloride | |
|---|---|
| Term | Fedratinib hydrochloride |
| Short definition | Fedratinib hydrochloride (feh-DRAH-tih-nib HY-droh-KLOR-ide) A drug used to treat adults with moderate- or high-risk myelofibrosis (MF), including primary MF, MF post Polycythemia vera and MF after essential thrombocythemia. It is also being studied in the treatment of other conditions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Fedratinib hydrochloride - (pronounced) (feh-DRAH-tih-nib HY-droh-KLOR-ide) A drug used to treat adults with moderate- or high-risk myelofibrosis (MF), including primary MF, MF post Polycythemia vera and MF after essential thrombocythemia. It is also being studied in the treatment of other conditions. Fedratinib hydrochloride blocks JAK2 and other proteins that can help prevent abnormal blood cells or cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called Inrebic
External links
- Medical encyclopedia article on Fedratinib hydrochloride
- Wikipedia's article - Fedratinib hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski